Patents by Inventor Angelo L. Rovati

Angelo L. Rovati has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5232937
    Abstract: Derivatives of N-phenylbenzamide with general formula (1) in which R.sub.1 is a cyano, nitro, halogen, hydrozy, C.sub.1 -C.sub.4 alkyl methyl, methoxy or tetrazol-5-yl group, R.sub.2 is hydrogen, hydroxy, or methoxy, R.sub.3 is a tetrazol-5-yl group or hydrogen, R.sub.4 and R.sub.5 are hydrogen if R.sub.3 is tetrazolyl but are independently selected from the group consisting of carboxy, methoxycarbonyl, ethoxycarbonyl and carbamoyl if R.sub.3 is hydrogen, and R.sub.6 is hydrogen or methyl. The derivatives have an anti-ulcer and anti-allergy activity.
    Type: Grant
    Filed: August 19, 1991
    Date of Patent: August 3, 1993
    Assignee: Rotta Research Laboratorium SpA.
    Inventors: Francesco Makovec, Walter Peris, Angelo L. Rovati
  • Patent number: 4978683
    Abstract: This inventions relates to a method of treating malignant tumors of the pancreatic, colic or gastric origin whose growth is increase by bioactive polypeptides comprising administering an anti-tumor effective amount of proglumide or pharmaceutical acceptables salt thereof to a patient afflicted with said malignant tumors.
    Type: Grant
    Filed: August 13, 1986
    Date of Patent: December 18, 1990
    Assignee: Rotta Research Laboratorium S.p.A.
    Inventors: Angelo L. Rovati, Claudio L. Rovati, Francesco Makovec
  • Patent number: 4870097
    Abstract: N-acylated derivatives of L-tryptophan of general formula (I), ##STR1## in which R is selected from the group consisting of: (a) a phenyl group, mono-substituted or di-substituted in the meta and para positions with halogens, linear or branched alkyl groups containing from 1 to 9 carbon atoms, the cyano group or the trifluoromethyl group, (b) a benzyloxy group, mono-substituted or di-substituted in the meta and para position with substituents selected from those indicated at (a), and (c) a benzydryloxy group. The derivatives are used in therapy, particularly for human pain relief, in the treatment of pathological conditions of the central nervous system and of pathological intestinal conditions.
    Type: Grant
    Filed: July 11, 1988
    Date of Patent: September 26, 1989
    Assignee: Rotta Research Laboratorium S.p.A.
    Inventors: Francesco Makovec, Rolando Chiste, Angelo L. Rovati